ᓄᓱᓪᓗᒍ ᐃᓕᓯᒃᑲᓐᓂᕈᒪᒍᕕᑦ ᖄᖓᓂᒃ
ᒥᒃᓵᓄᑦ
Will Rosellini is the President of CytoImmune Therapeutics, a clinical stage biotechnology company. Previously, he was Chief Executive Officer of Perimeter Medical and, prior to that, Chief Executive Officer of Nexeon Medsystems, a medical device manufacturing company that went public in 2017.
ᒪᓕᒃᑐᖅ
(20)
ᒪᓕᒃᑎᐅᔪᑦ
(20)
Will Rosellini ᓱᓕ ᓴᖅᑭᑦᑎᓯᒪᙱᓚᖅ ᑭᓱᑐᐃᓐᓇᕐᒥᒃ
ᓇᑲᑎᕆᓗᑎᑦ ᐊᔾᔨᙳᐊᕐᓂᒃ
